BRIEF-EMA Says EMA's CHMP Approved New Manufacturing Site For Active Substance Of Jcovden

BRIEF-EMA Says EMA's CHMP Approved New Manufacturing Site For Active Substance Of Jcovden

European Medicines Agency:

* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF JCOVDEN: 01/06/2022

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.